Corcept Therapeutics sells Korlym for hypercortisolism and develops other drugs that act on the hormone cortisol. It last closed at $63.62 on Nov 20, down 2.09% on the day. The next earnings report for CORT is expected around Tue, Feb 23, 2027, after the close. For the quarter ended Sep 2026, CORT reported EPS of $1.01 on revenue of $340.5M, with revenue up 64.0% from a year ago. Over its last 8 reports the stock moved an average of 7.8% the session after earnings. Over the last 12 months CORT insiders bought $3.3M of stock on the open market and sold $98.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is CORT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CORT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CORTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CORT · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, oversold
The stock is 19% below its 20 day and 56% below its 50 day average. It is 21% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 21), oversold. The nearest support is the Pivot S1 at $62.58, and the nearest resistance the Pivot at $63.85.
Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 7.7%/day
Key levels
$126.3852 week high+98.6%
$102.62100 day average+61.3%
$99.0350 day average+55.7%
$85.40Swing high (Jun 17)+34.2%
$77.18200 day average+21.3%
$75.9720 day average+19.4%
$64.90Pivot R1+2.0%
$63.85Pivot+0.4%
$63.62Last close
$62.58Pivot S1−1.6%
$28.6652 week low−55.0%
Indicators
RSI (14)
20.93
Oversold below 30
Oversold
MACD
-9.80
Below its signal line
Bearish
Stochastic
3.5
Near the bottom of its range
Oversold
ADX (14)
52.2
Strong downtrend
Williams %R
-96.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-136.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−12.6%
Change over 10 sessions
Bearish
ATR (14)
$4.87
Typical daily range, 7.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 17.3%/day
Key levels
$126.3852 week high+98.6%
$102.62100 day average+61.3%
$99.0350 day average+55.7%
$85.40Swing high (Jun 17)+34.2%
$77.18200 day average+21.3%
$75.9720 day average+19.4%
$64.90Pivot R1+2.0%
$63.85Pivot+0.4%
$63.62Last close
$62.58Pivot S1−1.6%
$28.6652 week low−55.0%
Indicators
RSI (14)
34.20
Weak, oversold below 30
Neutral
MACD
-0.04
Below its signal line
Bearish
Stochastic
2.8
Near the bottom of its range
Oversold
ADX (14)
39.9
Trending down
Williams %R
-98.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-164.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−43.6%
Change over 10 sessions
Bearish
ATR (14)
$11.00
Typical daily range, 17.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for CORT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CORT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CORT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CORTHow many large options trades hit CORT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CORT in the last 90 days.
From SEC Form 4 filings by CORT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CORT is in one of them and how their past CORT trades turned out.
Corcept Therapeutics is a pharmaceutical company based in Redwood City, California, that develops medicines acting on the hormone cortisol. Its main product is Korlym, along with a generic version of it, used to treat hypercortisolism, also called Cushing's syndrome. The company sells these products in the United States through sales representatives who call on physicians treating patients with the condition. It is also testing cortisol-related drug candidates for other conditions, including some cancers, ALS and a liver disease.